2004 Annual Meeting | Stroke Prevention in 2004

Date Friday 04/30/04

Time 01:15 PM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) Mitchell S. Elkind, MD, MS, F�鶹��ýӳ��

Topic(s) Cerebrovascular Disease and Interventional Neurology

Learning Objectives Upon completion:
Participants should be able to discuss the evidence linking inflammatory markers, sleep apnea, and the metabolic syndrome and carotid stenosis to risk of stroke; recognize when to look for and how to diagnose these conditions in patients with stroke; use markers of inflammation and measures of insulin resistance appropriately in the evaluation of stroke patients; refer patients appropriately for sleep studies; treat patients directly or refer them for appropriate treatment by others; decide when patients should undergo cerebral revascularization; and rationally choose between carotid endarterectomy or carotid angioplasty and stenting.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident

Event Timeline
01:15 PM - 01:25 PM		Introduction: A New Paradigm for Stroke Prevention Mitchell S. Elkind, MD, MS, F�鶹��ýӳ��
01:25 PM - 02:00 PM		Inflammation as a Stroke Risk Factor: The Role of CRP and Other Measures Mitchell S. Elkind, MD, MS, F�鶹��ýӳ��
02:00 PM - 02:45 PM		Sleep Apnea, Hypertension and Stroke Antonio Culebras, MD, FAHA, F�鶹��ýӳ��
02:45 PM - 03:00 PM		Break
03:00 PM - 03:45 PM		The Metabolic Syndrome and Insulin Resistance in Stroke Prevention Brett M. Kissela, MD, MS, F�鶹��ýӳ��
03:45 PM - 04:30 PM		Carotid Endarterectomy and Stenting: Just the Facts Helmi L. Lutsep, MD, F�鶹��ýӳ��
04:30 PM - 05:00 PM		Questions and Answers

Faculty Disclosures
Mitchell S. Elkind, MD, MS, F�鶹��ýӳ��	Dr. Elkind has received personal compensation for serving as an employee of American Heart Association. Dr. Elkind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Atria Academy.
	No disclosure on file
Antonio Culebras, MD, FAHA, F�鶹��ýӳ��	Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for MEDLINK NEUROLOGY. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for MEDLINK NEUROLOGY. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MEDLINK. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MEDLINK. Dr. Culebras has received publishing royalties from a publication relating to health care. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as a RESEARCH REVIEWER with DEPARTMENT OF DEFENSE. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as a REVIEWER with DOD.
Brett M. Kissela, MD, MS, F�鶹��ýӳ��	The institution of Dr. Kissela has received research support from NIH/NINDS. Dr. Kissela has a non-compensated relationship as a Board Member with AHA Regional Board that is relevant to �鶹��ýӳ�� interests or activities.
Helmi L. Lutsep, MD, F�鶹��ýӳ��	Dr. Lutsep has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbott. Dr. Lutsep has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Lutsep has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Coherex Medical. Dr. Lutsep has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/Mayo Cinic. Dr. Lutsep has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medscape Neurology.